[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.216.242. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
November 12, 2003

Psychological Aspects of Gifts From Drug CompaniesPsychological Aspects of Gifts From Drug Companies

Author Affiliations
 

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2003;290(18):2404-2405. doi:10.1001/jama.290.18.2404-a

To the Editor: Mr Dana and Dr Loewenstein1 stated that "Performing industry-supported research, physicians face an implicit demand for a positive finding to obtain further financial support." I have been responsible for several thousand registration trials, carried out in approximately 50 countries for 4 major pharmaceutical companies, and I have never known investigators to be selected on the basis of their results. Investigators are selected according to a number of criteria, including experience in conducting clinical trials, ability to recruit the type and number of patients needed in the agreed-upon time, the production of complete and accurate data, and an optimal clinical research infrastructure.

First Page Preview View Large
First page PDF preview
First page PDF preview
×